Cholangitis in Emergency Medicine Clinical Presentation
- Author: Adam J Rosh, MD; Chief Editor: Barry E Brenner, MD, PhD, FACEP more...
History
In 1877, Charcot described cholangitis as a triad of findings of right upper quadrant (RUQ) pain, fever, and jaundice. The Reynolds pentad adds mental status changes and sepsis to the triad. A spectrum of cholangitis exists, ranging from mild symptoms to fulminant overwhelming sepsis. With septic shock, the diagnosis can be missed in up to 25% of patients. Consider cholangitis in any patient who appears septic, especially in patients who are elderly, jaundiced, or who have abdominal pain. A history of abdominal pain or symptoms of gallbladder colic may be a clue to the diagnosis.
- Charcot's triad consists of fever, RUQ pain, and jaundice. It is reported in up to 50-70% of patients with cholangitis. However, recent studies believe it is more likely to be present in 15-20% of patients.
- Fever is present in approximately 90% of cases.
- Abdominal pain and jaundice is thought to occur in 70% and 60% of patients, respectively.
- Patients present with altered mental status 10-20% of the time and hypotension approximately 30% of the time. These signs, combined with Charcot's triad, constitute Reynolds pentad.
- Consequently, many patients with ascending cholangitis do not present with the classic signs and symptoms.[4]
- Most patients complain of RUQ pain; however, some patients (ie, elderly persons) are too ill to localize the source of infection.
- Other symptoms include the following:
- Jaundice
- Fever, chills, and rigors
- Abdominal pain
- Pruritus
- Acholic or hypocholic stools
- Malaise
- The patient's medical history may be helpful. For example, a history of the following increases the risk of cholangitis:
- Gallstones, CBD stones
- Recent cholecystectomy
- Endoscopic manipulation or ERCP, cholangiogram
- History of cholangitis
- History of HIV or AIDS: AIDS-related cholangitis is characterized by extrahepatic biliary edema, ulceration, and obstruction. The etiology is uncertain, but it may be related to cytomegalovirus or Cryptosporidium infections. The management of this condition is described below, although decompression is usually not necessary.
Physical
- In general, patients with cholangitis are quite ill and frequently present in septic shock without an apparent source of the infection.
- Physical examination may reveal the following:
- Fever (90%), although elderly patients may have no fever
- RUQ tenderness (65%)
- Mild hepatomegaly
- Jaundice (60%)
- Mental status changes (10-20%)
- Sepsis
- Hypotension (30%)
- Tachycardia
- Peritonitis (uncommon, and should lead to a search for an alternative diagnosis)
Causes
In Western countries, choledocholithiasis is the most common cause of acute cholangitis, followed by ERCP and tumors.
Any condition that leads to stasis or obstruction of bile in the CBD, including benign or malignant stricture, parasitic infection, or extrinsic compression by the pancreas, can result in bacterial infection and cholangitis. Partial obstruction is associated with a higher rate of infection than complete obstruction.
- CBD stones predispose patients to cholangitis.
- Approximately 10-15% of patients with cholecystitis have CBD stones.
- Approximately 1% of patients post cholecystectomy have retained CBD stones. Most CBD stones are immediately symptomatic, while some remain asymptomatic for years.
- Some CBD stones are formed primarily rather than secondarily to gallstones.
- Obstructive tumors cause cholangitis. Partial obstruction is associated with an increased rate of infection compared with that of complete neoplastic obstruction.
- Pancreatic cancer
- Cholangiocarcinoma[5]
- Ampullary cancer
- Porta hepatis tumors or metastasis
- Additional causes of cholangitis include the following:
- Strictures or stenosis
- Endoscopic manipulation of the CBD
- Choledochocele
- Sclerosing cholangitis (from biliary sclerosis)
- AIDS cholangiopathy
- Ascaris lumbricoides infections
Aron JH, Bowlus CL. The immunobiology of primary sclerosing cholangitis. Semin Immunopathol. Sep 2009;31(3):383-97. [Medline]. [Full Text].
Kashyap R, Mantry P, Sharma R, et al. Comparative analysis of outcomes in living and deceased donor liver transplants for primary sclerosing cholangitis. J Gastrointest Surg. Aug 2009;13(8):1480-6. [Medline].
van Erpecum KJ. Gallstone disease. Complications of bile-duct stones: Acute cholangitis and pancreatitis. Best Pract Res Clin Gastroenterol. 2006;20(6):1139-52. [Medline].
Kinney TP. Management of ascending cholangitis. Gastrointest Endosc Clin N Am. Apr 2007;17(2):289-306, vi. [Medline].
Jabara B, Fargen KM, Beech S, Slakey DR. Diagnosis of cholangiocarcinoma: a case series and literature review. J La State Med Soc. Mar-Apr 2009;161(2):89-94. [Medline].
Attasaranya S, Fogel EL, Lehman GA. Choledocholithiasis, ascending cholangitis, and gallstone pancreatitis. Med Clin North Am. Jul 2008;92(4):925-60, x. [Medline].
Rustemovic N, Cukovic-Cavka S, Opacic M, et al. Endoscopic ultrasound elastography as a method for screening the patients with suspected primary sclerosing cholangitis. Eur J Gastroenterol Hepatol. Jun 2010;22(6):748-53. [Medline].
Sharma BC, Agarwal N, Sharma P, Sarin SK. Endoscopic biliary drainage by 7 Fr or 10 Fr stent placement in patients with acute cholangitis. Dig Dis Sci. Jun 2009;54(6):1355-9. [Medline].
Itoi T, Kawai T, Sofuni A, et al. Efficacy and safety of 1-step transnasal endoscopic nasobiliary drainage for the treatment of acute cholangitis in patients with previous endoscopic sphincterotomy (with videos). Gastrointest Endosc. Jul 2008;68(1):84-90. [Medline].
Rosing DK, De Virgilio C, Nguyen AT, El Masry M, Kaji AH, Stabile BE. Cholangitis: analysis of admission prognostic indicators and outcomes. Am Surg. Oct 2007;73(10):949-54. [Medline].
Bornman PC, van Beljon JI, Krige JE. Management of cholangitis. J Hepatobiliary Pancreat Surg. 2003;10(6):406-14. [Medline].
Hanau LH, Steigbigel NH. Acute (ascending) cholangitis. Infect Dis Clin North Am. Sep 2000;14(3):521-46. [Medline].
Jain MK, Jain R. Acute bacterial cholangitis. Curr Treat Options Gastroenterol. Apr 2006;9(2):113-21. [Medline].
Lai EC. Management of severe acute cholangitis. Br J Surg. Jun 1990;77(6):604-5. [Medline].
Lee JG. Diagnosis and management of acute cholangitis. Nat Rev Gastroenterol Hepatol. Sep 2009;6(9):533-41. [Medline].
Lipsett PA, Pitt HA. Acute cholangitis. Surg Clin North Am. Dec 1990;70(6):1297-312. [Medline].
Muir CA. Acute ascending cholangitis. Clin J Oncol Nurs. Apr 2004;8(2):157-60. [Medline].
Qureshi WA. Approach to the patient who has suspected acute bacterial cholangitis. Gastroenterol Clin North Am. Jun 2006;35(2):409-23. [Medline].
Romagnuolo J, Bardou M, Rahme E, Joseph L, Reinhold C, Barkun AN. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med. Oct 7 2003;139(7):547-57. [Medline].
Sievert W, Vakil NB. Emergencies of the biliary tract. Gastroenterol Clin North Am. Jun 1988;17(2):245-64. [Medline].
Sinanan MN. Acute cholangitis. Infect Dis Clin North Am. Sep 1992;6(3):571-99. [Medline].
van den Hazel SJ, Speelman P, Tytgat GN, Dankert J, van Leeuwen DJ. Role of antibiotics in the treatment and prevention of acute and recurrent cholangitis. Clin Infect Dis. Aug 1994;19(2):279-86. [Medline].
Yusoff IF, Barkun JS, Barkun AN. Diagnosis and management of cholecystitis and cholangitis. Gastroenterol Clin North Am. Dec 2003;32(4):1145-68. [Medline].

